You are here

Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey

Last updated on December 6, 2018

FOR MORE INFORMATION
Study Location
Dokuz Eylul University Medical Faculty, Department of Chest Diseases
Balcova, Izmir, 35340 Turkey
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pneumococcal Diseases
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Serotype distribution and antibiotic sensitivity of pneumococcal isolates that causes
invasive pneumococcal diseases which are obtained from the blood, CSF, and/or all other
sterile body areas (catheter, pleural fluid, parasynthesis fluid, pericardial fluid,
synovial fluid, BAL) of the adults of 18 years of age or older with children that are
younger than 18 years old at these centers and laboratories will be defined.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Isolation of any other microorganism than pneumococcus at the same sample.

NCT01810861
Pfizer
Recruiting
Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.

Similar Trials

Pneumococcal Vaccines
NCT00574548
All Genders
60+
Years
Multiple Sites
Pneumococcal Vaccines, Infant, Chemically Induced Fever, Combination Drug Therapy
NCT00294294
All Genders
Psoriatic Arthritis, Psoriasis, Papulosquamous Skin Diseases
NCT00293722
All Genders
18+
Years
Toerwang-Samerberg,
Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey
Serotype Distribution And Antibiotic Susceptibility Of Streptococcus Pneumoniae Causing Invasive Diseases In Children And Adults: A Laboratory- Based Multicenter Retrospective Study
The aim of this study is to specify the serotype distribution of Streptococcus pneumoniae that causes invasive diseases at children and adults in Turkey.
Non-interventional observational study Descriptive analysis will be conducted.
Observational
Observational Model: Other
Time Perspective: Retrospective
Not Provided
Retention:   Samples Without DNA
Description:
Blood, CSF and/or other sterile body areas (catheter, pleural fluid, parasynthesis fluid, pericardial fluid, synovial fluid, BAL)
Non-Probability Sample

Pneumococcal isolates that are obtained from the blood, CSF and/or other sterile body areas (catheter, pleural fluid, parasynthesis fluid, pericardial fluid, synovial fluid, BAL) with the aim of routine laboratory diagnosis from the pediatric patients that are younger than 18 years old (?18), who are accepted to the pediatric clinic with the diagnosis of meningitides, bacteremia - sepsis or pneumonia, will be included in the trial.

S.pneumoniae isolates that meet the inclusion criteria and that are obtained from the invasive clinical samples of the adult patients that are over 18 years old (>18) and applied to the hospital are included in the trial.

Pneumococcal Diseases
Other: There is no intervention in this study
This is a non-interventional study.
Serotype distribution (this is a non-interventional study)
Serotype distribution both in pediatrics and adults (this is a non interventional study)
Intervention: Other: There is no intervention in this study
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
1
November 1, 2018
November 1, 2018   (Final data collection date for primary outcome measure)

Inclusion Criteria:

Serotype distribution and antibiotic sensitivity of pneumococcal isolates that causes invasive pneumococcal diseases which are obtained from the blood, CSF, and/or all other sterile body areas (catheter, pleural fluid, parasynthesis fluid, pericardial fluid, synovial fluid, BAL) of the adults of 18 years of age or older with children that are younger than 18 years old at these centers and laboratories will be defined.

Exclusion Criteria:

Isolation of any other microorganism than pneumococcus at the same sample.

Sexes Eligible for Study: All
Child, Adult, Senior
No

Contact: Pfizer CT.gov Call Center 1-800-718-1021 [email protected]
Contact: Pfizer Oncology Clinical Trial Information Service 1-877-369-9753 [email protected]
Turkey
 
 
NCT01810861
B1851148
No
Not Provided
Not Provided
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
November 2017

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now